MDL Sought for Apple Lawsuits Over AirTag Stalking Problems and Damages Caused By Unauthorized Tracking
Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Lehman Notes Lawsuit Filed Against UBS Over Deceptive Sales August 26, 2010 Staff Writers Add Your CommentsA financial fraud lawsuit has been filed against UBS by an Indiana couple who claim the brokerage firm sold them high risk Lehman structured notes while claiming they were safe and protected.ย ย The Lehman Brothers notes lawsuit was filed earlier this month before the Financial Industry Regulatory Authority (FINRA), and is the latest in a string of claims against UBS over problems with the structured notes. In addition to selling the couple the Lehman notes, the lawsuit claims that UBS also sold them its own structured notes, which the investors allege was a violation in spirit of an industry rule that disallows a broker to borrow from its customers.ย The UBS lawsuit seeks to recover the entire investment by the couple, which has not been disclosed, as well as attorneyโs fees, costs, and punitive damages in an amount of triple what the couple lost.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONLehman Brothers structured notes were a hybrid financial instrument, constructed from a combination of stocks, bonds, currencies, commodities and derivatives, which were promoted by some brokers as low-risk investments, even as Lehman Brothers faced substantial financial troubles. Although investors were told that the notes carried a guaranteed principal protection, that guarantee became worthless when Lehman filed for bankruptcy protection on September 15, 2008.FINRA is a non-governmental regulatory body that oversees more than 5,000 brokerage firms throughout the United States. Investors are able to resolve disputes against brokerage firms through FINRA for claims involving breach of fiduciary duty, negligence, misrepresentation, breach of contract, unauthorized trading and other claims that investments were improperly handled.A UBS class action lawsuit over Lehman structured notes was filed in 2008 in the U.S. District Court for the Southern District of New York, on behalf of all investors who were sold the investment by the brokerage firm. The complaint alleges that UBS brokers made false and misleading statements about Lehman Brothers Principal Protection Notes that omitted material facts about the risk associated with investing. However, according to financial fraud lawyers investigating Lehman Brothers claims on behalf of investors, most individuals are in a better position to recover their losses through a FINRA arbitration claim.Observers say that more UBS Lehman notes lawsuits could be coming from states and the Securities Exchange Commission could file criminal charges as financial law enforcement investigators look deeper into the brokerage firm’s practices in promoting and selling the notes. Tags: Financial Fraud, FINRA, FINRA Arbitration, Indiana, Lehman Brothers, UBS Image Credit: |More Lawsuit Stories Syfovre, Izervay Side Effects May Thicken Retinal Nerves, Research Warns August 13, 2026 Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials August 12, 2026 MDL Sought for Apple Lawsuits Over AirTag Stalking Problems and Damages Caused By Unauthorized Tracking August 12, 2026 1 Comments Michael August 26, 2010 What UBS did in the US, Credit Suisse practiced in Switzerland. It is estimated that Credit Suisse sold principal-protected Lehman notes worth about 700 million Swiss francs in Switzerland alone. The clients were mostly small investors with little or no experience in capital markets. Just as UBS, Credit Suisse failed to inform the customers about the true nature of these products. Just look at a factsheet of a Lehman note sold be Credit Suisse. In the section entitled โrisksโ you will find neither โLehmanโ nor โcreditworthiness of the issuerโ nor anything similar. Instead – throughout the entiire document – you will find five times the promise โprincipal protectedโ โ but not a single time in conjunction with Lehman, at least not explicitly. What in my view proves the accusation of deception is the fact that in a sales brochure issued by Credit Suisse, these opportunity notes carry the risk label โlowโ (see brochure entitled โAnlegen und Vorsorgenโ), whereas in the disclaimer of such a note, there is talk of โhighโ risks. It is obvious that one was text written by marketing people and the other by legal staff and that Credit Suisse failed to reconcile the two. The version the relationship managers stuck to is of course the first one, as you can see from an e-mail sent by my relationship manager. He recommends the Lehman note as an alternative to a fixed deposit and claims that it is FULLY principal-protected (capital letters by Credit Suisse). No mention of Lehman, issuer or issuer risk. In the mean-time, Credit Suisse was forced to buy back about 150 Mio. Swiss francs worth of these notes โ not by our financial market supervisory authority, which is totally useless, but by public pressure. This is of course barely more than 20% of what Credit Suisse had sold. At the end of February 2010, Credit Suisse was still advertising structured products on its website with the slogan โProtect your portfolio against unexpected risks with structured derivatives.โ The Opportunity Note that was then presented featured repeated emphasis on one-hundred-percent capital protection without a single mention of issuer risk. The Opportunity Note was then awarded a lovely โlowโ risk value. However, one look at the fine-print disclaimer of such an Opportunity Note would immediately reveal the phrase โThese investment products are complex structured derivatives and involve a high degree of risk.โ Depending on whether the print is large or small, the risk ranges from low to high; sometimes the Opportunity Note protects against unexpected risks, sometimes it involves a high degree of risk in itself. Even the brochure โSpecial Risks in Securities Tradingโ by the Swiss Bankers Association โ a brochure which is sent to the customers when they open up a depot, i.e. years before they may actually buy a principal-protected product or, depending on the circumstances, also afterwards โ even this brochure fails to explain the relationship between issuer risk and principal protection. As a matter of fact, this brochure even cements what principal protection means to the layman anyway: โWhat is the maximum possible loss? The maximum possible loss for the buyer of a structured product with capital protection is the difference between the purchase price and the amount of the capital protection.โ (Special Risks in Securities Trading, Swiss Bankers Association, Edition 2001, in use until 2008, p. 14) I hope that justice will one day prevail in both the US and Switzerland. CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials (Posted: yesterday)C.R. Bard and its Becton Dickinson parent company face more than 3,700 Bard PowerPort lawsuits that claim the port catheters are defectively designed.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (07/17/2026)New Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026)Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (05/29/2026) Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (Posted: 2 days ago)A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.MORE ABOUT: DUPIXENT LAWSUITCTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026)Dupixent MDL Judge To Meet With Lawyers for Initial Case Management Conference in October 2026 (06/25/2026) Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims (Posted: 3 days ago)Manufacturer wants the Judicial Panel on Multidistrict Litigation to reject a proposal by a group of plaintiffs to consolidate all federal Abbott spinal cord stimulator lawsuits.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITLawsuit Over Spinal Cord Stimulator Removal Claims Device Caused Numbness, Incontinence (08/06/2026)Spine Stimulator Injury Lawyers Seek Leadership Roles in Boston Scientific MDL (07/31/2026)Spinal Cord Stimulator Reprogramming Caused Electric Shocks, Worsening Pain: Lawsuit (07/27/2026)
Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials August 12, 2026
MDL Sought for Apple Lawsuits Over AirTag Stalking Problems and Damages Caused By Unauthorized Tracking August 12, 2026
Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials (Posted: yesterday)C.R. Bard and its Becton Dickinson parent company face more than 3,700 Bard PowerPort lawsuits that claim the port catheters are defectively designed.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (07/17/2026)New Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026)Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (05/29/2026)
Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (Posted: 2 days ago)A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.MORE ABOUT: DUPIXENT LAWSUITCTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026)Dupixent MDL Judge To Meet With Lawyers for Initial Case Management Conference in October 2026 (06/25/2026)
Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims (Posted: 3 days ago)Manufacturer wants the Judicial Panel on Multidistrict Litigation to reject a proposal by a group of plaintiffs to consolidate all federal Abbott spinal cord stimulator lawsuits.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITLawsuit Over Spinal Cord Stimulator Removal Claims Device Caused Numbness, Incontinence (08/06/2026)Spine Stimulator Injury Lawyers Seek Leadership Roles in Boston Scientific MDL (07/31/2026)Spinal Cord Stimulator Reprogramming Caused Electric Shocks, Worsening Pain: Lawsuit (07/27/2026)